{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:23:23Z","timestamp":1778927003260,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11910-020-1024-x","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T03:02:38Z","timestamp":1583204558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Update on Pediatric Optic Neuritis"],"prefix":"10.1007","volume":"20","author":[{"given":"Ryan A.","family":"Gise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gena","family":"Heidary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"issue":"12","key":"1024_CR1","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain."},{"issue":"2","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2):127\u201337.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","volume":"72","author":"B Banwell","year":"2009","unstructured":"Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009;72(3):232\u20139.","journal-title":"Neurology."},{"issue":"12","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","volume":"77","author":"A Langer-Gould","year":"2011","unstructured":"Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77(12):1143\u20138.","journal-title":"Neurology."},{"issue":"2","key":"1024_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45(2):244\u201350.","journal-title":"Neurology"},{"issue":"2","key":"1024_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1212\/01.wnl.0000224757.69746.fb","volume":"67","author":"M Wilejto","year":"2006","unstructured":"Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology. 2006;67(2):258\u201362.","journal-title":"Neurology."},{"issue":"3","key":"1024_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajo.2014.05.036","volume":"158","author":"MJ Wan","year":"2014","unstructured":"\u2022 Wan MJ, Adebona O, Benson LA, Gorman MP, Heidary G. Visual outcomes in pediatric optic neuritis. Am J Ophthalmol. 2014;158(3):503\u2013507 e502 This study was important because it is one of the first to describe visual outcomes in a large cohort of pediatric patients at a tertiary care center.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaapos.2011.05.020","volume":"15","author":"AT Waldman","year":"2011","unstructured":"Waldman AT, Stull LB, Galetta SL, Balcer LJ, Liu GT. Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies. J AAPOS. 2011;15(5):441\u20136.","journal-title":"J AAPOS"},{"issue":"9 Suppl 2","key":"1024_CR9","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1212\/WNL.0000000000002822","volume":"87","author":"EA Yeh","year":"2016","unstructured":"Yeh EA, Graves JS, Benson LA, Wassmer E, Waldman A. Pediatric optic neuritis. Neurology. 2016;87(9 Suppl 2):S53\u20138.","journal-title":"Neurology."},{"issue":"2","key":"1024_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1091-8531(99)70078-9","volume":"3","author":"KM Brady","year":"1999","unstructured":"Brady KM, Brar AS, Lee AG, Coats DK, Paysse EA, Steinkuller PG. Optic neuritis in children: clinical features and visual outcome. J AAPOS. 1999;3(2):98\u2013103.","journal-title":"J AAPOS"},{"issue":"6","key":"1024_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1469-8749.2008.03136.x","volume":"51","author":"G Alper","year":"2009","unstructured":"Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol. 2009;51(6):480\u20136.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1024_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.spen.2017.04.004","volume":"24","author":"MY Chang","year":"2017","unstructured":"Chang MY, Pineles SL. Pediatric optic neuritis. Semin Pediatr Neurol. 2017;24(2):122\u20138.","journal-title":"Semin Pediatr Neurol"},{"issue":"Suppl 1","key":"1024_CR13","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WNO.0000000000000551","volume":"37","author":"M Borchert","year":"2017","unstructured":"Borchert M, Liu GT, Pineles S, Waldman AT. Pediatric optic neuritis: what is new. J Neuroophthalmol. 2017;37(Suppl 1):S14\u201322.","journal-title":"J Neuroophthalmol"},{"issue":"3","key":"1024_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.msard.2013.10.008","volume":"3","author":"AT Waldman","year":"2013","unstructured":"Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, et al. Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. Mult Scler Relat Disord. 2013;3(3):326\u201334.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"1024_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/WCO.0b013e32832b4c47","volume":"22","author":"RC Dale","year":"2009","unstructured":"Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2009;22(3):233\u201340.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"1024_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"issue":"2","key":"1024_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000528","volume":"6","author":"YYM Wong","year":"2019","unstructured":"Wong YYM, de Mol CL, van der Vuurst de Vries RM, van Pelt E, Ketelslegers IA, Catsman-Berrevoets CE, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e528.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"1024_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ejpn.2008.09.003","volume":"13","author":"G Cakmakli","year":"2009","unstructured":"Cakmakli G, Kurne A, Guven A, et al. Childhood optic neuritis: the pediatric neurologist's perspective. Eur J Paediatr Neurol. 2009;13(5):452\u20137.","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"1024_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1212\/01.wnl.0000344163.65326.48","volume":"72","author":"GR Bonhomme","year":"2009","unstructured":"Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, et al. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology. 2009;72(10):881\u20135.","journal-title":"Neurology."},{"issue":"9","key":"1024_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/adc.2009.175422","volume":"96","author":"M Absoud","year":"2011","unstructured":"Absoud M, Cummins C, Desai N, et al. Childhood optic neuritis clinical features and outcome. Arch Dis Child. 2011;96(9):860\u20132.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1024_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","volume":"49","author":"CF Lucchinetti","year":"1997","unstructured":"Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Leavitt JA, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997;49(5):1413\u20138.","journal-title":"Neurology."},{"issue":"6","key":"1024_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ana.24409","volume":"77","author":"N Heussinger","year":"2015","unstructured":"Heussinger N, Kontopantelis E, Gburek-Augustat J, Jenke A, Vollrath G, Korinthenberg R, et al. Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol. 2015;77(6):1076\u201382.","journal-title":"Ann Neurol"},{"issue":"1","key":"1024_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13311-015-0396-0","volume":"13","author":"JN Brenton","year":"2016","unstructured":"Brenton JN, Banwell BL. Therapeutic approach to the Management of Pediatric Demyelinating Disease: multiple sclerosis and acute disseminated encephalomyelitis. Neurotherapeutics. 2016;13(1):84\u201395.","journal-title":"Neurotherapeutics."},{"issue":"10","key":"1024_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261\u20137.","journal-title":"Mult Scler"},{"issue":"9 Suppl 2","key":"1024_CR25","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1212\/WNL.0000000000002824","volume":"87","author":"S Tenembaum","year":"2016","unstructured":"Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, et al. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology. 2016;87(9 Suppl 2):S59\u201366.","journal-title":"Neurology."},{"issue":"8","key":"1024_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/archneurol.2012.249","volume":"69","author":"AM Quek","year":"2012","unstructured":"Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012;69(8):1039\u201343.","journal-title":"Arch Neurol"},{"issue":"2","key":"1024_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","volume":"71","author":"A McKeon","year":"2008","unstructured":"McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008;71(2):93\u2013100.","journal-title":"Neurology."},{"issue":"2","key":"1024_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"\u2022 Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389 This article provides the foundation for the current diagnostic criteria of Neuromyeltitis opticain both children and adults.","journal-title":"Neurology"},{"issue":"9451","key":"1024_CR29","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106\u201312.","journal-title":"Lancet."},{"key":"1024_CR30","doi-asserted-by":"crossref","unstructured":"Sepulveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, et al. Epidemiology of NMOSD inCatalonia: Influence of the new 2015 criteria in incidence and prevalence estimates. Mult Scler. 2018;24(14):1843\u20131851.","DOI":"10.1177\/1352458517735191"},{"issue":"11","key":"1024_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84(11):1165\u201373.","journal-title":"Neurology."},{"issue":"12","key":"1024_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1212\/WNL.0b013e3181f39a66","volume":"75","author":"N Collongues","year":"2010","unstructured":"Collongues N, Marignier R, Zephir H, et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology. 2010;75(12):1084\u20138.","journal-title":"Neurology."},{"issue":"4","key":"1024_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","volume":"86","author":"M Absoud","year":"2015","unstructured":"Absoud M, Lim MJ, Appleton R, et al. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry. 2015;86(4):470\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1024_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/1352458513507822","volume":"20","author":"L Kremer","year":"2014","unstructured":"Kremer L, Mealy M, Jacob A, et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler. 2014;20(7):843\u20137.","journal-title":"Mult Scler"},{"issue":"3","key":"1024_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.0000000000002283","volume":"86","author":"T Chitnis","year":"2016","unstructured":"Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, et al. Clinical features of neuromyelitis optica in children: US network of pediatric MS centers report. Neurology. 2016;86(3):245\u201352.","journal-title":"Neurology."},{"issue":"1","key":"1024_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2013.07.003","volume":"50","author":"YD Fragoso","year":"2014","unstructured":"Fragoso YD, Ferreira ML, Oliveira EM, Domingues RB, Ribeiro TA, Brooks JB, et al. Neuromyelitis optica with onset in childhood and adolescence. Pediatr Neurol. 2014;50(1):66\u20138.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1024_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016;13(1):280.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1024_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/ene.12898","volume":"23","author":"ED van Pelt","year":"2016","unstructured":"van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol. 2016;23(3):580\u20137.","journal-title":"Eur J Neurol"},{"issue":"6","key":"1024_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474\u201381.","journal-title":"Neurology."},{"issue":"3","key":"1024_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276\u201383.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1024_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0037-1604404","volume":"49","author":"EM Hennes","year":"2018","unstructured":"Hennes EM, Baumann M, Lechner C, Rostasy K. MOG Spectrum disorders and role of MOG-antibodies in clinical practice. Neuropediatrics. 2018;49(1):3\u201311.","journal-title":"Neuropediatrics."},{"issue":"6","key":"1024_CR42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, et al. Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Mult Scler. 2015;21(6):678\u201388.","journal-title":"Mult Scler"},{"issue":"4","key":"1024_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","volume":"89","author":"M Bonnan","year":"2018","unstructured":"Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2018;89(4):346\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1024_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","volume":"21","author":"Y Hacohen","year":"2019","unstructured":"Hacohen Y, Banwell B. Treatment approaches for MOG-Ab-associated demyelination in children. Curr Treat Options Neurol. 2019;21(1):2.","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"1024_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/brain\/awx075","volume":"140","author":"Y Hacohen","year":"2017","unstructured":"Hacohen Y, Ciccarelli O, Hemingway C. Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination. Brain. 2017;140(5):1172\u20134.","journal-title":"Brain."},{"issue":"8","key":"1024_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rostasy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013;9(8):455\u201361.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1024_CR47","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000081","volume":"2","author":"Y Hacohen","year":"2015","unstructured":"Hacohen Y, Absoud M, Deiva K, Hemingway C, Nytrova P, Woodhall M, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e81.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1024_CR48","doi-asserted-by":"crossref","unstructured":"Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, et al. Serial Anti-Myelin OligodendrocyteGlycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. JAMA Neurol. 2020;77(1):82\u201393.","DOI":"10.1001\/jamaneurol.2019.2940"},{"issue":"4","key":"1024_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/dmcn.13649","volume":"60","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Rossor T, Mankad K, Chong W', Lux A, Wassmer E, et al. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease. Dev Med Child Neurol. 2018;60(4):417\u201323.","journal-title":"Dev Med Child Neurol"},{"key":"1024_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","volume":"195","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J, L\u00f3pez-Chiriboga ASS, Fryer JP, Leavitt JA, et al. Myelin Oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8\u201315.","journal-title":"Am J Ophthalmol"},{"key":"1024_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jns.2019.03.014","volume":"400","author":"H Song","year":"2019","unstructured":"Song H, Zhou H, Yang M, Xu Q, Sun M, Wei S. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: a cohort study in China. J Neurol Sci. 2019;400:83\u20139.","journal-title":"J Neurol Sci"},{"key":"1024_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.03.003","volume":"83","author":"Q Chen","year":"2018","unstructured":"Chen Q, Zhao G, Huang Y, Li Z, Sun X, Lu P, et al. Clinical characteristics of pediatric optic neuritis with myelin Oligodendrocyte glycoprotein seropositive: a cohort study. Pediatr Neurol. 2018;83:42\u20139.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1024_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","volume":"86","author":"M Baumann","year":"2015","unstructured":"Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86(3):265\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1024_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.msard.2018.11.026","volume":"28","author":"RN Narayan","year":"2019","unstructured":"\u2022\u2022 Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Mult Scler Relat Disord. 2019;28:86\u201390 This study provides insight into the relationship between optic nerve and retinal structure and visual function in pediatric patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1024_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261(1):17\u201326.","journal-title":"J Neurol"},{"issue":"Pt 2","key":"1024_CR56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126(Pt 2):276\u201384.","journal-title":"Brain."},{"issue":"1\u20132","key":"1024_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2013.05.012","volume":"331","author":"A Waschbisch","year":"2013","unstructured":"Waschbisch A, Atiya M, Schaub C, Derfuss T, Schwab S, Lee DH, et al. Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity. J Neurol Sci. 2013;331(1\u20132):72\u20135.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1024_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2010","unstructured":"Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010;81(1):109\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1024_CR59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","volume":"115","author":"Optic Neuritis Study G","year":"2008","unstructured":"Optic Neuritis Study G. Visual function 15 years after optic neuritis: a final follow-up report from the optic neuritis treatment trial. Ophthalmology. 2008;115(6):1079\u201382 e1075.","journal-title":"Ophthalmology."},{"issue":"9","key":"1024_CR60","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group. N Engl J Med. 1992;326(9):581\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"1024_CR61","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"\u2022\u2022 Hacohen Y, Wong YY, Lechner C, et al. Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2018;75(4):478\u201387 This article provides evidence for what treatments are effecttive in patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.","journal-title":"JAMA Neurol"},{"key":"1024_CR62","doi-asserted-by":"crossref","unstructured":"Gmuca S, Xiao R, Weiss PF, Waldman AT, Gerber JS. Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder. Mult Scler Demyelinating Disord. 2018;3,3.","DOI":"10.1186\/s40893-018-0035-9"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-1024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-020-1024-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-1024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:44:25Z","timestamp":1614732265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-020-1024-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s11910-020-1024-x","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"3 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Standards"}},{"value":"The authors declare that they have no conflict(s) of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"4"}}